- From Prototype to Production: Building a Validation Strategy That Scales with Manufacturing Volume
- Orthodontics leader Dr. Rolf Behrents dies
- Managing AI in Medical Technology: From Innovation to Compliance
- Mississippi to distribute $13.5M for youth mental health programs
- ‘Heroism doesn’t scale’: Leaders warn of cracks in behavioral health system
- Beyond FIFO: How intelligent triage is modernizing access and referrals — 4 takeaways
- Double-digit joint replacement growth, 150+ robotic surgery programs: Tenet’s ASC acuity push is paying off
- Why digital health initiatives fail: 35 healthcare leaders weigh in
- Utah hospital opens multispecialty pediatric clinic
- Navigating uncertainty: How to scale intelligent care and make it stick
- ‘Depth over breadth’: Health systems eye quality of AI applications, not number
- 7 hospital, health system layoffs in April
- Trump pulls surgeon general nominee, taps Fox News contributor, radiologist
- 1st state enacts Medicaid work rules under HR 1: What healthcare leaders need to know
- Delta Dental of Illinois appoints senior VP of finance
- Tennessee GI practices suffers data breach
- Mayo Clinic: Remote patient monitoring can detect transplant complications
- States scramble to submit Medicaid ‘provider revalidation’ plans to CMS
- 3 factors fueling dentistry’s financial squeeze
- University of Texas Medical Branch names CIO
- MetroHealth primary care providers seek unionization: 5 things to know
- Maine hospital promotes dual CFO-COO to CEO
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- Seven Things Every Medical Device Manufacturer Must Know Before Integrating AI
- ChristianaCare plans $58M health campus to expand outpatient care
- The industry playbooks that dentistry should be using to level-up
- Outpatient EP is here — but are ASCs ready?
- 3 notable DSO deals in 2 weeks
- Tenet deployed $125M on 7 ASC acquisitions in Q1, eyes more deals
- The Structural Tension at the Heart of MedTech
- The Structural Tension at the Heart of MedTech
- MercyOne to shutter physician practice, urgent care
- Cybersecurity Tactics for Medical IoT Devices
- Cybersecurity Tactics for Medical IoT Devices
- One GI, Oshi Health partner on virtual GI care
- From Toddlers to Teens: The Hidden Complexities of Bringing Pediatric Wearables to Market
- From Toddlers to Teens: The Hidden Complexities of Bringing Pediatric Wearables to Market
- Drug use by state in 2026
- Dental hygienists, assistants not satisfied with their income
- Franciscan Health, US HealthVest partner on behavioral care
- Delta Dental to pay $2.2M penalty for violating cybersecurity regulations
- 6 DSOs expanding on the West Coast
- 7 behavioral health facility, service closures, layoffs in 2026
- Top 10 dental, DSO stories in April
- Tenet Healthcare met Q1's volume curveballs with 'old-fashioned discipline'
- Dentrix Ascend integrates Pearl’s dental AI
- Trump pulls surgeon general nomination of Casey Means, names Nicole Saphier as new pick
- New Medical Guidelines Urge More Fiber, Less Bathroom Scrolling on Your Phone
- Sleep and Anxiety Medications in Pregnancy Appear to Pose Little Harm
- Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's
- BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio
- Waystar kicks off 2026 with strong growth as it targets AI at $100B RCM labor pool
- Merck's growth products Winrevair, Ohtuvayre trending in opposite directions
- Trump's Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Nasal Spray Flu Vaccines Create 'Battlefield' In Adults' Noses
- Prehabilitation Slashes Post-Op Complications By Half, Review Says
- Understanding Emotions Could Be Key To Quelling Chronic Pain
- Meth Caused 1 In 6 Heart Attacks Over A Decade, Study Finds
- States Rush To Figure Out How To Enforce Trump’s Medicaid Work Requirements
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- Cigna to exit ACA market, pursue strategic alternatives for eviCore unit
- Amarox recalls batch of antidepressants in UK over packaging mix-up
- Bayer earns FDA untitled letter for Nubeqa's 'attention-grabbing visuals'
- Merck bats for heart disease awareness with new baseball-inspired campaign
- Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
- Europe’s drug regulator sets up new group to counter vaccine hesitancy
- Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model
- 8 behavioral healthcare M&A deals in 2026
- Maryland autism therapy provider expands in-home services in Colorado
- 22 behavioral health executive moves to know
- The ‘significant opportunity’ Talkspace will bring to UHS
- Healthcare costs remain a top concern for voters as midterms loom: KFF
- UHS-owned behavioral health facility to lay off 648 employees
- Nonprofit health systems are falling short on governance capabilities, report warns
- Novartis rounds out $23B US investment push with plans for North Carolina API plant
- Teladoc Health reports strong momentum behind BetterHelp insurance shift, CEO says
- AI Tool May Help Identify ADHD in Kids Long Before Typical Diagnosis
- Viz.ai partners with National Rural Health Association to expand AI understanding, access to rural hospitals
- FDA Moves to Real-Time Clinical Trial Patient Monitoring, Faster Drug Review
- AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
- With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
- Universal Health Services' Q1 2026 earnings growth dampened by volume hits
- AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde
- Regeneron's quarterly sales of Eylea drop below $1B for the first time in 8 years
- Only 1 in 4 employers able to ‘absorb’ increasing health benefit costs without impacting business
- Dementia Screening Safe For Families, Trial Finds
- Online Program Soothes Post-Trauma Stress In Injured Children
- Mental Defeat Can Worsen Chronic Pain, Researchers Say
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
- New GSK CEO’s first quarter boosted by Shingrix surge as Exdensur stumbles in switch trial
- AstraZeneca restarts £300M investment in UK, but Merck not budging
- Chiesi lays out $1.9B to bolster rare disease offerings with KalVista buyout
- US drugmaker’s reputations shift quickly amid political pressures, job cuts: survey
- Trump’s Medicaid Work Mandate Debuting in Nebraska to Much Dismay
- Saving Lives by Changing Lives: The Next Frontier in Suicide Prevention
- Pfizer looks to jump start Elrexfio with topline win in second-line myeloma
- The push to expand access to emergency contraception
- Humana pulls back the curtain on planning for 2027 MA bids
- On Capitol Hill, health system CEOs agree to 'rational reworking' of site-neutral payments
- Novartis CEO calls for 'complete rethink' of Europe's drug pricing policies
- Secret to Surviving 'Perfect Mom' Posts on Social Media Revealed
- Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Getting All Your Ducks in a Row to IPO: Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Remarks to the Small Business Capital Formation Advisory Committee
- FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
- CDC Warns of Antibiotic-Resistant Salmonella in Backyard Flocks
- Listen to the Latest ‘KFF Health News Minute’
- AI-driven coding platform Arintra rolls out new documentation improvement capabilities
- Florida Delays Children's Health Insurance Expansion as Uninsured Rate Rises
- Interoperability was Never the Finish Line in Healthcare
- Interoperability was Never the Finish Line in Healthcare
- IKS Health to acquire TruBridge in $557M deal
- FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
- Rocket sells priority review voucher for $180M after Kresladi gene therapy approval
- Big companies position themselves for payday from $50B federal rural health fund
- AZ's Breztri nabs FDA asthma nod, adding fuel to blockbuster launch
- Daylight Saving Time Fails to Boost Daily Steps, Study Finds
- Metabolic Syndrome Tied To Cancer Risk
- Mail-In Colon Cancer Test Kits Offer Affordable Screening
- U.S. Dentists Still Overprescribing Opioids Compared To Other Nations, Puerto Rico
- An Urgent Care Treated Her Allergic Reaction. An ER Monitored Her — For $6,700.
- Big Companies Position Themselves for Payday From $50B Federal Rural Health Fund
- Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million
- CCS deploys enterprise-wide agentic AI across chronic care operations
- Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says
- Medical professional liability premiums rise for 7th straight year
- UChicago Medicine, Artisight partner on system-wide rollout of smart hospital platform
- First Gene Therapy for Genetic Hearing Loss, Otarmeni, Gains FDA Approval
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Blood Glucose Monitors Improve Control Among Type 2 Diabetes Patients
- Regaining Weight After Quitting Your GLP-1 Drug? A Simple Procedure Might Help, Study Says
- Late-Night Noshing Could Contribute To Stress-Related Bathroom Problems
- New Treatment Targets Unaddressed Major Symptom Of Depression Through Joy, Pleasure and Purpose
- The Help That Many Older Americans Need Most
- Florida Delays Children’s Health Insurance Expansion as Uninsured Rate Rises
- Why Pricier Olive Oil May Be Better For Your Brain
- Your Internal Signal to Stop Eating is More Complex Than Previously Thought
- Gounder Culls the News, From Ticks and AI to Who Might Lead CDC
- FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
- Green Lighting Capital Formation: Remarks at the SEC International Institute on Capital Formation
- With ‘lessons learned,’ Kite prepares to hit the ground running as next-gen CAR-T decision looms
- Former Tobacco Executive Takes CDC Role
- New Plan Could Speed Medicare Coverage for Innovative Devices
- Heated Socks Sold at Costco Recalled After Burn Reports
- First Measles Case of the Year Reported in New Jersey
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- CMS, FDA Announce RAPID Coverage Pathway to Accelerate Device Reimbursement
- Does Motherhood Shield You From Stroke?
- These Fun Pursuits Help Middle-Aged Folks Protect Brain Health, Study Finds
All the electronic records of Dr. Tom Shimabukuro, the director of the CDC’s Immunization Safety Office, have gone missing:
https://www.zerohedge.com/political/top-cdc-vaccine-safety-officers-records-missing-hhs-says
Top CDC Vaccine Safety Officer's Records Missing, HHS Says
By Zachary Stieber - April 13, 2025The Epoch Times
Records from a top official at the Centers for Disease Control and Prevention are missing, the CDC’s parent agency has informed a U.S. senator.
Department of Health and Human Services (HHS) officials told Sen. Ron Johnson (R-Wis.) in March that “they are having difficulty locating records,” Johnson said on April 9.
More recently, HHS officials said that Dr. Tom Shimabukuro’s records “remain lost and, potentially, removed from HHS’s email system altogether,” Johnson added.
Shimabukuro, the CDC, and HHS did not respond to requests for comment by publication time.
Shimabukuro is director of the CDC’s Immunization Safety Office, which researches the safety of vaccines, according to the CDC’s website. He frequently spoke at vaccine meetings, at times offering false information, The Epoch Times previously reported.
He was also involved in vaccine research, including monitoring vaccine safety in pregnant women.
Johnson, the chairman of the Senate’s Permanent Subcommittee on Investigations, disclosed the situation with Shimabukuro’s records in a letter to Attorney General Pam Bondi, FBI Director Kash Patel, and Juliet Hodgkins, the acting inspector general of HHS.
“Dr. Shimabukuro’s potential mishandling of his official records is highly concerning. His actions, if true, would have directly obstructed my multi-year oversight efforts of the COVID-19 vaccines and would be in clear violation of my November 19, 2024 demand to HHS, CDC, and the Food and Drug Administration to ‘preserve all records referring or relating to the development, safety, and efficacy of the COVID-19 vaccines,’” Johnson wrote.
“Furthermore, given Dr. Shimabukuro’s role at CDC, which includes monitoring adverse events relating to the COVID-19 vaccines, his communications are directly responsive to my January 28, 2025, subpoena to HHS for records relating to the development and safety of the COVID-19 vaccines. Any attempt to obstruct or interfere with my investigatory efforts would be grounds for contempt of Congress.”
The senator also said that if Shimabukuro mishandled records, he may have violated laws such as the Federal Records Act.
Johnson asked Bondi, Patel, and Hodgkins to investigate whether Shimabukuro and other officials within HHS deleted or destroyed agency records, including any attempts to avoid congressional oversight or Freedom of Information Act requests.
Spokespersons for the Department of Justice and HHS Office of Inspector General (OIG) confirmed in emails to The Epoch Times that the agencies received the letter, and declined to comment further. The FBI declined to comment.
Another HHS official, National Institutes of Health scientist Dr. David Morens, was previously revealed—through emails obtained via the Freedom of Information Act—to have talked about how he learned to make messages disappear after requests under the act were lodged.
“So I think we are all safe,” he wrote in one of the emails in 2021.
Johnson also requested an HHS inspector general investigation of Morens. The HHS hasn’t confirmed whether any probes were initiated, according to Johnson.
“To date, the HHS OIG refuses to confirm that it has initiated any of these investigations. The HHS OIG’s lack of transparency with Congress is unacceptable,” Johnson wrote. “If the allegations regarding Dr. Shimabukuro’s mishandling of agency records are true, then it will certainly raise questions about the effectiveness of the HHS OIG’s oversight and cast doubt on whether the HHS OIG actually did what I asked it to do nineteen months ago.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















